Microbot Medical Inc. (MBOT)

US — Healthcare Sector
Peers: SDC  ISRG  INND  POAI  STAA  BDX  WST  RMD  GCTK  GMVD  STSS    ZJYL  MHUA 

Automate Your Wheel Strategy on MBOT

With Tiblio's Option Bot, you can configure your own wheel strategy including MBOT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MBOT
  • Rev/Share 0.0
  • Book/Share 1.7011
  • PB 1.5755
  • Debt/Equity 0.0048
  • CurrentRatio 16.1944
  • ROIC -0.3177

 

  • MktCap 97492504.0
  • FreeCF/Share -0.5467
  • PFCF -10.4774
  • PE -5.0861
  • Debt/Assets 0.0045
  • DivYield 0
  • ROE -0.8472

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 4
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Microbot Medical Inc. (MBOT)

  • IPO Date 1992-03-25
  • Website https://www.microbotmedical.com
  • Industry Medical - Instruments & Supplies
  • CEO Mr. Harel Gadot
  • Employees 20
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.